These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27758789)

  • 1. Questions hang over European patent for hepatitis C drug after ruling.
    Stafford N
    BMJ; 2016 Oct; 355():i5493. PubMed ID: 27758789
    [No Abstract]   [Full Text] [Related]  

  • 2. Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.
    da Fonseca EM; Shadlen K; Bastos FI
    N Engl J Med; 2019 Feb; 380(7):605-607. PubMed ID: 30763192
    [No Abstract]   [Full Text] [Related]  

  • 3. Indian hepatitis C drug patent decision shakes public health community.
    't Hoen EFM
    Lancet; 2016 Jun; 387(10035):2272-2273. PubMed ID: 27238944
    [No Abstract]   [Full Text] [Related]  

  • 4. Sofosbuvir faces fresh patent challenge in Europe.
    Stafford N
    BMJ; 2017 Mar; 356():j1632. PubMed ID: 28360141
    [No Abstract]   [Full Text] [Related]  

  • 5. Betting on hepatitis C: how financial speculation in drug development influences access to medicines.
    Roy V; King L
    BMJ; 2016 Jul; 354():i3718. PubMed ID: 27815237
    [No Abstract]   [Full Text] [Related]  

  • 6. Patents: problem or panacea?
    Uzoigwe CE; McCann J; Iacob G
    BMJ; 2016 Aug; 354():i4526. PubMed ID: 27554799
    [No Abstract]   [Full Text] [Related]  

  • 7. Compulsory licences for direct acting antiviral drugs for hepatitis C.
    Cattaneo A; Maciocco G
    BMJ; 2016 Oct; 355():i5314. PubMed ID: 27707734
    [No Abstract]   [Full Text] [Related]  

  • 8. Wales approves new hepatitis C drug while England deliberates.
    Ozieranski P; King L
    BMJ; 2016 Dec; 355():i6499. PubMed ID: 27908876
    [No Abstract]   [Full Text] [Related]  

  • 9. Campaigners challenge patent applications for hepatitis C drug in five countries.
    Bagcchi S
    BMJ; 2015 Jun; 350():h2938. PubMed ID: 26032985
    [No Abstract]   [Full Text] [Related]  

  • 10. High cost of new drugs.
    Mazzucato M
    BMJ; 2016 Jul; 354():i4136. PubMed ID: 27815284
    [No Abstract]   [Full Text] [Related]  

  • 11. Role Of Generics In Treatment Of Hepatitis C Infection.
    Umar M; Akhter TS; Akbar I; Nisar G; Osama M; Akhter TS
    J Ayub Med Coll Abbottabad; 2016; 28(4 Suppl 1):S890-S894. PubMed ID: 28782339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal Disease Screening and Treatment - The Egyptian Example.
    Haseltine WA
    N Engl J Med; 2020 Mar; 382(12):1081-1083. PubMed ID: 32187465
    [No Abstract]   [Full Text] [Related]  

  • 13. China rejects patent on hepatitis C drug sofosbuvir.
    Kmietowicz Z
    BMJ; 2015 Jun; 350():h3429. PubMed ID: 26105994
    [No Abstract]   [Full Text] [Related]  

  • 14. A pill too hard to swallow: how the NHS is limiting access to high priced drugs.
    Gornall J; Hoey A; Ozieranski P
    BMJ; 2016 Jul; 354():i4117. PubMed ID: 27469086
    [No Abstract]   [Full Text] [Related]  

  • 15. What does it mean to put new hepatitis C drugs on a list of essential medicines?
    Urrutia J; Porteny T; Daniels N
    BMJ; 2016 Apr; 353():i2035. PubMed ID: 27106956
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO issues guidelines on HCV amid drug cost controversy.
    Slomski A
    JAMA; 2014 Jun; 311(22):2262-3. PubMed ID: 24915242
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug executives should take a Hippocratic oath.
    More B
    Nature; 2018 Mar; 555(7698):561. PubMed ID: 29595775
    [No Abstract]   [Full Text] [Related]  

  • 18. Public participation in decision-making on the coverage of new antivirals for hepatitis C.
    Kieslich K; Ahn J; Badano G; Chalkidou K; Cubillos L; Hauegen RC; Henshall C; Krubiner CB; Littlejohns P; Lu L; Pearson SD; Rid A; Whitty JA; Wilson J
    J Health Organ Manag; 2016 Aug; 30(5):769-85. PubMed ID: 27468625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline: New HCV drugs should go to sickest patients.
    Kuehn BM
    JAMA; 2014 Sep; 312(11):1084-5. PubMed ID: 25226461
    [No Abstract]   [Full Text] [Related]  

  • 20. Idenix files three patent infringement lawsuits in Europe.
    Pharm Pat Anal; 2014 May; 3(3):225. PubMed ID: 25129897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.